-transparent.png){kind=logo}
Tenascin (hexabrachion, cytotactin) is an extracellular matrix glycoprotein whose expression is strongly increased in hyperproliferative skin diseases, as shown by immunohistochemistry with polyclonal sera. In this study we describe a new monoclonal antibody (T2H5) against human tenascin. The specificity of T2H5 was validated by sequential immunoprecipitation of tenascin with polyclonal sera. T2H5 was used to analyse the presence of tenascin in basal cell carcinoma. Using Western blotting, at least two forms of tenascin were found, with approximate molecular weights of 210 and 300 kDa. In cultured human skin fibroblasts only the high molecular weight form was found.
Related Publications
A A Verstraeten, and
E J Mackie, and
P C Hageman, and
J Hilgers, and
D J Schol, and
G J De Jongh, and
J Schalkwijk
January 1996,
Anticancer research,
A A Verstraeten, and
E J Mackie, and
P C Hageman, and
J Hilgers, and
D J Schol, and
G J De Jongh, and
J Schalkwijk
November 1989,
The Journal of pathology,
A A Verstraeten, and
E J Mackie, and
P C Hageman, and
J Hilgers, and
D J Schol, and
G J De Jongh, and
J Schalkwijk
January 2006,
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica,
A A Verstraeten, and
E J Mackie, and
P C Hageman, and
J Hilgers, and
D J Schol, and
G J De Jongh, and
J Schalkwijk
July 1995,
The British journal of surgery,
A A Verstraeten, and
E J Mackie, and
P C Hageman, and
J Hilgers, and
D J Schol, and
G J De Jongh, and
J Schalkwijk
September 2008,
Oncology reports,
A A Verstraeten, and
E J Mackie, and
P C Hageman, and
J Hilgers, and
D J Schol, and
G J De Jongh, and
J Schalkwijk
June 2002,
Experimental dermatology,
A A Verstraeten, and
E J Mackie, and
P C Hageman, and
J Hilgers, and
D J Schol, and
G J De Jongh, and
J Schalkwijk
January 2013,
Journal of the European Academy of Dermatology and Venereology : JEADV,
A A Verstraeten, and
E J Mackie, and
P C Hageman, and
J Hilgers, and
D J Schol, and
G J De Jongh, and
J Schalkwijk
October 2012,
The British journal of dermatology,
A A Verstraeten, and
E J Mackie, and
P C Hageman, and
J Hilgers, and
D J Schol, and
G J De Jongh, and
J Schalkwijk
May 2016,
Epigenomics,
A A Verstraeten, and
E J Mackie, and
P C Hageman, and
J Hilgers, and
D J Schol, and
G J De Jongh, and
J Schalkwijk
January 1994,
British journal of cancer,
